A post on X this week informed its readers that "researchers proved coffee drinkers have measurably worse memory than non-drinkers," and that the memory benefit of coffee "has nothing to do with caffeine." It linked to a real paper. I read the paper. It is a good one. The post is not.
The study comes from John Cryan's group at APC Microbiome Ireland (University College Cork), with collaborators in Parma. The lab is the reason most of us have heard the phrase "gut brain axis." The design is more rigorous than nearly everything in this corner of the newsletter: preregistered, two clinical trial numbers, a blinded arm, shotgun metagenomics, urine and stool metabolomics, cortisol, cytokines, a cold pressor stress test, and a battery of cognitive and mood questionnaires. The paper reports what it found and is unusually forthcoming about what it could not.
Two bits of housekeeping before the claims. First, this study cites two papers that already appeared in this newsletter: the 2024 Nature Microbiology analysis of 22,000 microbiome samples that tied coffee to Lawsonibacter (January 6, 2025), and the NHANES cognition paper from Inner Mongolia Medical University (November 10, 2025). My confirmation bias has a citation trail. Second, the study was funded by the Institute for Scientific Information on Coffee, the industry group backed by Illy, Lavazza, and Peet's that I first flagged in December. The senior authors also disclose honoraria and research funding from Nestlé, whose instant coffee was the study beverage. None of that makes the data wrong. It is another filter to read through.
The study in one paragraph. 62 healthy adults aged 30 to 50 living in Ireland, recruited between September 2021 and January 2023. 31 had never drunk coffee. 31 drank three to five cups a day. Everyone was measured once at baseline. The nondrinkers then went home (with thirty euros). The coffee drinkers gave up all caffeine for two weeks, were measured again, and were then randomized, blinded, to three weeks of either caffeinated (n = 16) or decaffeinated (n = 15) Nescafé Classic instant coffee, four sachets a day, milk and sugar to taste. Stool, urine, saliva, blood, food diaries, and questionnaires at each visit, with extra stool samples during the washout and reintroduction. The primary outcome was microbiome composition and function. Everything about mood, memory, and cognition was secondary.
The abstract says "non-coffee drinkers demonstrated better memory performance." The results section, describing the same episodic memory test (a modified Rey word list), says "at the baseline visit, performance was similar between CD and NCD." The figure shows a medium sized difference on the total score and nothing in the text explains the gap between the two sentences. That is a real inconsistency, and it sits in the one finding the post built its headline on.
What the post inflatedNothing was proved. This is a cross sectional comparison of 31 self selected coffee drinkers and 31 self selected abstainers on a secondary outcome. The authors write, in the limitations, that the study "may not have been sufficiently powered to detect small to medium effect sizes for outcomes beyond our primary hypothesis." Memory is one of those outcomes. The nondrinkers were also less emotionally reactive and less impulsive at baseline, which is exactly the sort of difference you would expect between people who chose coffee and people who chose not to, before any coffee is involved.
Accurate. Two weeks off all caffeine, including tea and dark chocolate, then three weeks of blinded caffeinated or decaffeinated instant coffee, block randomized and stratified by sex. Withdrawal symptoms (headache, drowsiness) rose on days two and four and had largely settled by day 14. Cravings, interestingly, never budged.
The caveat the post skippedThe blinding covers caffeine, not coffee. Every participant in the second phase knew they were back on four cups a day. There is no arm that stayed off coffee, and the never drinkers were only measured on day zero. So any change that appears in both the caffeinated and the decaf groups is consistent with coffee's nonstimulant chemistry, and equally consistent with the return of a ritual people had been missing for two weeks. The paper cannot tell those apart, and does not claim to.
The paper's own subheading is "coffee intake drives targeted shifts in gut microbial populations without changing overall diversity." Alpha diversity did differ between drinkers and never drinkers, but in the drinkers it did not change across the washout or the reintroduction, and beta diversity did not move with reintroduction either. Seven strains moved. Cryptobacterium curtum and two Eggerthella species were what habitual drinkers had more of at baseline, and C. curtum fell steadily during the washout. What bloomed when coffee came back, on day 21, in both arms, was Veillonella. Veillonella parvula rose significantly only in the decaf group.
What the post inflated"Fundamentally reshaped" describes a handful of strains shifting inside an otherwise stable community. And the post has the direction backwards on its named bacteria: Cryptobacterium and Eggerthella are the ones coffee drinkers carry, the ones that drifted toward the nondrinker profile when coffee stopped, and the ones that had not recovered within three weeks of restarting. The species the reintroduction actually boosted was the one the post did not name.
Comparing the start and end of the reintroduction, both groups improved on perceived stress, the Beck depression inventory, and the impulsivity scale. That part is in the paper. The "driving" is not. The link from bacteria to mood is a Sankey diagram of pairwise statistical associations among species, metabolites, and questionnaire scores. It is a map of what correlated with what, in 31 people, and the authors present it as exactly that.
What the post inflatedTwo things. First, the same scores had also improved during the two weeks off coffee (impulsivity and emotional reactivity both fell during the washout), so "coffee made people calmer" and "a five week study with repeated questionnaires made people report being calmer" are hard to separate. Second, the stress physiology did not move at all. Salivary cortisol, the cortisol awakening response, and the response to the cold pressor test were the same in drinkers and nondrinkers, unchanged by washout, and unchanged by either coffee. The calm is on the questionnaires, not in the saliva.
The caffeinated group improved on the paced auditory serial addition test (attention and vigilance) and reported lower trait anxiety and lower psychological distress at the end of the intervention. The decaf group did not. The decaf group instead reported better sleep, more physical activity, and less emotional reactivity. Caffeine also did something to blood pressure worth noting: two weeks of abstinence lowered systolic and diastolic pressure in the habitual drinkers, and then the caffeinated group's systolic pressure fell again relative to decaf during the reintroduction. That is the AHA's tolerance story from August, observed in miniature.
What the post inflated"Slashed" is doing a lot of work for a within group change in sixteen people over three weeks. The authors describe "distinct benefits based on coffee type," which is a fair reading. Also worth knowing: the attention test had improved after the washout too, which the authors attribute, plainly, to people getting better at the test.
On the word list test, significant post intervention improvement was seen only in the decaf group. On the CANTAB paired associates task, errors fell in the decaf group and not the caffeinated group. The authors suggest "non-caffeine components of coffee may improve learning and memory," and then, in the next clause, that "there is also a chance of learning effect." The task was given at baseline and at the end. People do better on memory tests the second time.
What the post inflatedThe decaf group is fifteen people. The mechanism (polyphenols, digestive tract, neural pathways) was not tested anywhere in the paper; the metabolomics show that phenolic metabolites rise with either coffee and that individuals vary widely in how they process them. That is a hypothesis the authors offer for future work. The post reported it as the finding. And the decaf group, for what it is worth, also reported sleeping better, which is the oldest known memory intervention.
It would be easy to leave the impression that this is a weak study dressed up. It is not. It is a small study honestly reported, and its real findings are more interesting than the ones that went viral.
The metabolomics are the strongest part. Habitual drinkers carry more theophylline, paraxanthine, and hippuric acid in their stool and less of three neuroactive compounds: indole 3 propionic acid, indole 3 carboxaldehyde, and GABA. Two weeks off coffee, the caffeine metabolites fall and the indole compound rises. Three weeks back on, the caffeine metabolites return only in the caffeinated arm, while the phenolic metabolites return in both. The paper's nine key metabolites, and the species they travel with, are a plausible parts list for anyone who wants to run the properly controlled trial next.
The immune findings are quietly striking. Coffee drinkers had lower C reactive protein and higher IL 10 at baseline. Two weeks of abstinence raised CRP and TNF alpha. When whole blood was challenged with bacterial endotoxin, IL 6 secretion roughly halved after reintroduction of either coffee. If you wanted a mechanism for the epidemiology in this corner of the newsletter (lower diabetes, lower cardiovascular disease, lower mortality, decaf included), a mild anti inflammatory effect that does not depend on caffeine is the kind of thing you would hope to find.
And the authors are candid. They name the missing stool transit measurement, the possibility that the nondrinkers were in mild tea withdrawal on day zero, the practice effects, the power limits, and the fact that a homogeneous group of healthy Irish thirty and forty somethings tells you about healthy Irish thirty and forty somethings. Most of what the post got wrong, the paper had already corrected in its own discussion section.
The bias disclosure, updated. I have now upgraded the espresso machine and read a Nestlé funded study of Nescafé Classic that says the coffee is fine and the memory effect might be a practice effect. My confirmation bias remains fully intact and appropriately caffeinated. The study drank four sachets of instant a day. Your machine may differ.
A careful, preregistered study of 62 healthy adults found that habitual coffee drinkers carry a distinct set of gut bacteria and metabolites, that most of it drifts back toward the nondrinker profile within two weeks off coffee, and that a mild anti inflammatory signal returns with either regular or decaf. The memory headline is a secondary outcome in fifteen people that the authors themselves flag as a possible practice effect. Nothing was proved. Drink whichever coffee you like.
Sources
Primary source: Boscaini S, Bastiaanssen TFS, Moloney GM, et al. Habitual coffee intake shapes the gut microbiome and modifies host physiology and cognition. Nature Communications 17:3439 (2026). Received 21 October 2024, published 21 April 2026. doi.org/10.1038/s41467-026-71264-8 (open access)
Trial registrations: NCT05927038 and NCT05927103. Data: MetaboLights MTBLS13401 and MTBLS13494; ENA PRJEB108545; code at github.com/thomazbastiaanssen/coffee
The post under review: @thesupermanmx on X, September 2026. x.com/thesupermanmx
Cited by this paper and previously in WAiR: Manghi P, et al. Coffee consumption is associated with intestinal Lawsonibacter asaccharolyticus abundance and prevalence across multiple cohorts. Nature Microbiology 9:3120 (2024), WAiR January 6, 2025. Li J, et al. Exploring the impact of coffee consumption and caffeine intake on cognitive performance in older adults. Nutrition Journal 24 (2025), WAiR November 10, 2025.
Related WAiR: The AHA Comes Out for Coffee (August 2026). The full running tally is in The Coffee Ledger.